Burroughs Wellcome Fund

History

The Burroughs Wellcome Fund was founded in 1955 as an American extension of the Wellcome Trust in England. These foundations trace their origins to the American pharmaceutical magnates Henry Wellcome and Silas Burroughs, who founded Burroughs Wellcome and Co. in England in 1880. This pharmaceutical company was one of the four large organizations that eventually merged to become GlaxoSmithKline.

After Silas Burroughs died in 1895, Henry Wellcome expanded the company into several continents and numerous countries, including the United States. In 1924, Wellcome consolidated all of the company's holdings under a corporate umbrella named The Wellcome Foundation Ltd. When he died in 1936, his will vested all of the corporate shares in a new charity entity – the Wellcome Trust. The Trust's purpose was to use profits from the Wellcome Foundation to advance research in medicine and medical history.

In 1955, Sir Henry Dale, one of the Trust's original trustees and its chair for 21 years, and William N. Creasy, president and chair of Burroughs Wellcome Co. USA, created a U.S. extension of the Wellcome Trust called the Burroughs Wellcome Fund. From 1955 to 1993, it operated as a corporate foundation to support scientific research. In 1993 a $400 million gift from the trustees allowed it to become an independent entity with no ties to the Wellcome Foundation or to GlaxoSmithKline, which by 2000 had purchased all shares of Wellcome Foundation.

Activities

Since its founding, the BWF has funded medical and biological science research across the United States and Canada. This has mainly consisted of individual recognition and funding like the Investigator in the Pathogenesis of Infectious Disease Award, the Physician-Scientist Institutional Award, and the Innovation in Regulatory Science Award. The BWF also supports larger research projects conducted by multiple teams, such as a report on "The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic."

One example of large-scale research supported in part by the fund was the genetic sequencing of Plasmodium falciparum, the parasite behind most malaria deaths. The BWF partnered with the World Health Organization and the Department of Defense to fund this research at the University of Pennsylvania. In addition to financial support, the Fund facilitated collaboration among the research participants.

The Fund is a sponsor of the North Carolina Teacher of the Year program through the North Carolina Department of Public Instruction.

In 2013, BWF created the Innovation in Regulatory Science Award to fund regulatory science researchers in the U.S. and Canada.

References

References

1. [http://www.nihbest.org/2017best-practices-workshop/ Proceeding of the BEST Practices Workshop]. Retrieved on January 16, 2020
2. [https://www.rtp.org/company/burroughs-wellcome-fund/ Research Triangle Park Foundation]. Retrieved on January 23, 2020
3. [https://www.bwfund.org/about Burroughs Wellcome Fund]. Retrieved on January 23, 2020
4. "Burroughs Wellcome Fund {{!}} NCpedia".
5. "Assistant Professor Ivalyo Ivanov wins a Burroughs Wellcome Fund’s Investigator in the Pathogenesis of Infectious Disease Award".
6. "Burroughs Wellcome Fund award expands opportunities for physician-scientists".
7. "Innovation in Regulatory Science Awards {{!}} Research Funding".
8. [https://www.nap.edu/read/12799/chapter/1 Institutes of Medicine]. Retrieved on January 23, 2020.
9. (20 October 2002). "Database Lets Researchers Worldwide Access the Genome of the Malarial Parasite Plasmodium falciparum".
10. (27 October 2004). "Strategies to Leverage Research Funding: Guiding DOD's Peer Reviewed Medical Research Programs". The National Academies Press.
11. (27 December 2019). "West Pine Teacher Mariah Morris Making Most of Her Statewide, National Platform".
12. Dance, Amber. (April 17, 2013). "Regulatory Science: Researchers in the Pipeline". Nature.